A separation of clinical from epidermal thinning effect in the topical glucocorticoid clobetasone butyrate
- PMID: 320995
- DOI: 10.1111/j.1365-2133.1977.tb05187.x
A separation of clinical from epidermal thinning effect in the topical glucocorticoid clobetasone butyrate
Abstract
Clobetasone butyrate ointment has been shown to be more effective in treating psoriasis and eczema than flurandrenolone ointment yet to cause less epidermal thinning in a human experimental model. This is an indication that the clinical activity of topical glucocorticoids may not necessarily be inseparable from their propensity to cause atrophy of the skin.
Similar articles
-
Clobetasone butyrate, a new topical corticosteroid: clinical activity and effects on pituitary-adrenal axis function and model of epidermal atrophy.Br Med J. 1975 Sep 13;3(5984):626-8. doi: 10.1136/bmj.3.5984.626. Br Med J. 1975. PMID: 1164639 Free PMC article.
-
The effect of clobetasone butyrate and other topical steroids on skin thickness of the domestic pig.Br J Dermatol. 1976 May;94(5):545-50. doi: 10.1111/j.1365-2133.1976.tb05144.x. Br J Dermatol. 1976. PMID: 1268065
-
Clinical evaluation of clobetasone butyrate in the treatment of children with atopic eczema, and its effect on plasma corticosteroid levels.Curr Med Res Opin. 1976;4(3):223-8. doi: 10.1185/03007997609109308. Curr Med Res Opin. 1976. PMID: 949903
-
Calcipotriene and betamethasone dipropionate for the topical treatment of plaque psoriasis.Expert Rev Clin Pharmacol. 2016 Jun;9(6):789-97. doi: 10.1080/17512433.2016.1179574. Epub 2016 May 13. Expert Rev Clin Pharmacol. 2016. PMID: 27089906 Review.
-
Hydrocortisone 17-butyrate: a new topical corticosteroid preliminary report.Drugs. 1976;12(4):249-57. doi: 10.2165/00003495-197612040-00001. Drugs. 1976. PMID: 786608 Review.
Cited by
-
Epidermal thinning: evaluation of commercial corticosteroids.Arch Dermatol Res. 1980;267(1):7-24. doi: 10.1007/BF00416917. Arch Dermatol Res. 1980. PMID: 7387177
-
Topical corticosteroids: clinical pharmacology and therapeutic use.Drugs. 1980 Feb;19(2):119-34. doi: 10.2165/00003495-198019020-00004. Drugs. 1980. PMID: 7363838
-
Dose-response relationship of topically applied methylprednisolone aceponate (MPA) in healthy volunteers.Eur J Clin Pharmacol. 1992;43(2):157-9. doi: 10.1007/BF01740663. Eur J Clin Pharmacol. 1992. PMID: 1425873 Clinical Trial.
-
Topical corticosteroids and unwanted local effects. Improving the benefit/risk ratio.Drug Saf. 1994 May;10(5):406-12. doi: 10.2165/00002018-199410050-00005. Drug Saf. 1994. PMID: 8037890 Review.
-
Topical treatments for chronic plaque psoriasis.Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD005028. doi: 10.1002/14651858.CD005028.pub3. Cochrane Database Syst Rev. 2013. PMID: 23543539 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources